Cargando…
RHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn’s disease associated with Mycobacterium paratuberculosis
BACKGROUND: Mycobacterium avium subspecies paratuberculosis (MAP) has been implicated as an etiological agent of Crohn’s disease (CD), a debilitating chronic inflammatory bowel disease. Clarithromycin (CLA), clofazimine (CLO), rifabutin (RIF) and other antibiotics have been used individually or in c...
Autores principales: | Alcedo, Karel P., Thanigachalam, Saisathya, Naser, Saleh A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908774/ https://www.ncbi.nlm.nih.gov/pubmed/27307791 http://dx.doi.org/10.1186/s13099-016-0115-3 |
Ejemplares similares
-
A single capsule formulation of RHB-104 demonstrates higher anti-microbial growth potency for effective treatment of Crohn’s disease associated with Mycobacterium avium subspecies paratuberculosis
por: Qasem, Ahmad, et al.
Publicado: (2016) -
Exploring the role of Mycobacterium avium subspecies paratuberculosis in the pathogenesis of type 1 diabetes mellitus: a pilot study
por: Naser, Saleh A, et al.
Publicado: (2013) -
TNFα inhibitors exacerbate Mycobacterium paratuberculosis infection in tissue culture: a rationale for poor response of patients with Crohn’s disease to current approved therapy
por: Qasem, Ahmad, et al.
Publicado: (2018) -
Is Mycobacterium avium paratuberculosis the Trigger in the Crohn’s Disease Spectrum?
por: Oken, Harry A., et al.
Publicado: (2017) -
Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenario
por: Hermon-Taylor, John
Publicado: (2009)